BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Diagnosis
45 results:

  • 1. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
    Liu X; Shen Q; Wen Y; Jiang Z; Ma Z; Zeng P; He J; Liao Y; Huang Y; Huang J
    Am J Clin Oncol; 2024 Apr; 47(4):149-154. PubMed ID: 38054473
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
    Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
    [No Abstract]    [Full Text] [Related]  

  • 4. [Primary synovial sarcoma of lung: a clinicopathological analysis of 12 cases].
    Zhang XW; Wei JG; Sun JP; Xu ZG; Cheng Q; Zhang L; Kong LF
    Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1120-1125. PubMed ID: 37899317
    [No Abstract]    [Full Text] [Related]  

  • 5. HOXA9 gene promotor methylation and copy number variation of sox2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer.
    Abou-Zeid A; Hashad D; Baess A; Mosaad M; Tayae E
    BMC Cancer; 2023 Apr; 23(1):329. PubMed ID: 37038139
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4-deficient undifferentiated tumor: A case report.
    Minoshima A; Sugita S; Segawa K; Aoyama T; Ito M; Daimon F; Takenami T; Kido T; Moriya J; Nishikiori H; Hasegawa T
    Diagn Cytopathol; 2023 May; 51(5):E149-E154. PubMed ID: 36772934
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Application Value Analysis of Seven-Autoantibody Panel in the lung cancer Screening in Yunnan.
    Li W; Sun Y; Xu N
    Comput Intell Neurosci; 2022; 2022():2368155. PubMed ID: 35832243
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
    Mu Y; Li J; Xie F; Xu L; Xu G
    J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The value of sox2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
    Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
    Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
    Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
    Ren Z; Ding HM; Qian X; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
    [No Abstract]    [Full Text] [Related]  

  • 12. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
    Chen P; Lu W; Chen T
    J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. SWI/SNF-deficient thoraco-pulmonary neoplasms.
    Sesboue C; Le Loarer F
    Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.
    Chatzopoulos K; Boland JM
    Virchows Arch; 2021 Jan; 478(1):21-30. PubMed ID: 33409598
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer.
    Chen SS; Li K; Wu J; Peng ZY; Wang ZD; Wang JC; Xu CW; Zhu CL; Li BC; Ren H; Tang SC; Sun X
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):223-233. PubMed ID: 32691153
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Downregulation of miRNA-126-3p is associated with progression of and poor prognosis for lung squamous cell carcinoma.
    Chen SW; Lu HP; Chen G; Yang J; Huang WY; Wang XM; Huang SP; Gao L; Liu J; Fu ZW; Chen P; Zhai GQ; Luo J; Li XJ; Huang ZG; Li ZY; Gan TQ; Yang DP; Mo WJ; Zhou HF
    FEBS Open Bio; 2020 Aug; 10(8):1624-1641. PubMed ID: 32598517
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exosomal Long Non-Coding RNAs in lung Diseases.
    Poulet C; Njock MS; Moermans C; Louis E; Louis R; Malaise M; Guiot J
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438606
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer.
    Mu Y; Xie F; Sun T
    J Clin Lab Anal; 2020 Aug; 34(8):e23349. PubMed ID: 32372513
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
    Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
    J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The diagnostic efficiency of seven autoantibodies in lung cancer.
    Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
    Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.